| 000 | 01556 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516130722.0 | ||
| 264 | 0 | _c20130402 | |
| 008 | 201304s 0 0 eng d | ||
| 022 | _a1532-1827 | ||
| 024 | 7 |
_a10.1038/bjc.2012.557 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDelpech, Y | |
| 245 | 0 | 0 |
_aClinical benefit from neoadjuvant chemotherapy in oestrogen receptor-positive invasive ductal and lobular carcinomas. _h[electronic resource] |
| 260 |
_bBritish journal of cancer _cFeb 2013 |
||
| 300 |
_a285-91 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aCarcinoma, Ductal, Breast _xdrug therapy |
| 650 | 0 | 4 |
_aCarcinoma, Lobular _xdrug therapy |
| 650 | 0 | 4 | _aChemotherapy, Adjuvant |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMastectomy, Segmental |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoadjuvant Therapy |
| 650 | 0 | 4 |
_aReceptors, Estrogen _xmetabolism |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aCoutant, C | |
| 700 | 1 | _aHsu, L | |
| 700 | 1 | _aBarranger, E | |
| 700 | 1 | _aIwamoto, T | |
| 700 | 1 | _aBarcenas, C H | |
| 700 | 1 | _aHortobagyi, G N | |
| 700 | 1 | _aRouzier, R | |
| 700 | 1 | _aEsteva, F J | |
| 700 | 1 | _aPusztai, L | |
| 773 | 0 |
_tBritish journal of cancer _gvol. 108 _gno. 2 _gp. 285-91 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/bjc.2012.557 _zAvailable from publisher's website |
| 999 |
_c22402719 _d22402719 |
||